Abbott Laboratories shares owned by Landmark Financial Advisors
Quarter-by-quarter ownership of Abbott Laboratories (ABT) shares owned by Landmark Financial Advisors
from 13F filings
Historical chart of Landmark Financial Advisors investment in Abbott Laboratories
Tip: Access up to 7 years of quarterly data
All positions including Abbott Laboratories held by Landmark Financial Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Abbott Laboratories by Landmark Financial Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $642k | 5.8k | 110.07 |
2023-09-30 | $553k | 5.7k | 96.85 |
2023-06-30 | $601k | 5.5k | 109.02 |
2023-03-31 | $550k | 5.4k | 101.26 |
2022-12-31 | $607k | 5.5k | 109.79 |
2022-09-30 | $527k | 5.4k | 96.79 |
2022-06-30 | $556k | 5.1k | 108.70 |
2022-03-31 | $591k | 4.9k | 120.00 |
2021-12-31 | $664k | 4.7k | 140.68 |
2021-09-30 | $536k | 4.5k | 119.91 |
2021-06-30 | $518k | 4.5k | 115.88 |
2021-03-31 | $536k | 4.5k | 119.91 |
2020-12-31 | $495k | 4.5k | 110.74 |
2020-09-30 | $485k | 4.5k | 108.50 |
2020-06-30 | $416k | 4.5k | 93.06 |
2020-03-31 | $397k | 4.5k | 89.03 |
2019-12-31 | $405k | 4.5k | 90.83 |
2019-09-30 | $378k | 4.5k | 83.52 |
2019-06-30 | $380k | 4.5k | 83.96 |
2019-03-31 | $361k | 4.5k | 79.78 |
2018-12-31 | $327k | 4.5k | 72.28 |
2018-09-30 | $331k | 4.5k | 73.20 |
2018-06-30 | $275k | 4.5k | 60.83 |
2018-03-31 | $271k | 4.5k | 59.97 |
2017-12-31 | $257k | 4.5k | 56.88 |
2017-09-30 | $241k | 4.5k | 53.37 |
2017-06-30 | $219k | 4.5k | 48.50 |
2017-03-31 | $200k | 4.5k | 44.32 |
2016-09-30 | $208k | 4.9k | 42.37 |
2016-06-30 | $287k | 7.3k | 39.28 |
2016-03-31 | $221k | 5.3k | 41.66 |
2015-12-31 | $261k | 5.8k | 44.78 |
2015-09-30 | $237k | 5.9k | 40.12 |
2015-06-30 | $289k | 5.9k | 48.94 |
2015-03-31 | $274k | 5.9k | 46.41 |
2014-12-31 | $270k | 5.9k | 45.75 |
More positions owned by Landmark Financial Advisors
View all positions for Landmark Financial Advisors